Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 8,391us-gaap_CashAndCashEquivalentsAtCarryingValue $ 7,279us-gaap_CashAndCashEquivalentsAtCarryingValue
Marketable securities, current 50,209us-gaap_AvailableForSaleSecuritiesCurrent 58,390us-gaap_AvailableForSaleSecuritiesCurrent
Collaboration receivable 7,248us-gaap_OtherReceivables 18,094us-gaap_OtherReceivables
Prepaid expenses and other current assets 832us-gaap_PrepaidExpenseAndOtherAssetsCurrent 2,246us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 66,680us-gaap_AssetsCurrent 86,009us-gaap_AssetsCurrent
Marketable securities, non-current   16,364us-gaap_MarketableSecuritiesNoncurrent
Property and equipment, net 557us-gaap_PropertyPlantAndEquipmentNet 686us-gaap_PropertyPlantAndEquipmentNet
Other assets 1,159us-gaap_OtherAssetsNoncurrent 1,059us-gaap_OtherAssetsNoncurrent
Total assets 68,396us-gaap_Assets 104,118us-gaap_Assets
Current liabilities:    
Accounts payable 2,074us-gaap_AccountsPayableCurrent 1,689us-gaap_AccountsPayableCurrent
Accrued clinical and development expenses 5,998thld_AccruedClinicalAndDevelopmentLiabilitiesCurrent 7,444thld_AccruedClinicalAndDevelopmentLiabilitiesCurrent
Accrued liabilities 3,180us-gaap_AccruedLiabilitiesCurrent 3,161us-gaap_AccruedLiabilitiesCurrent
Deferred revenue, current 14,722us-gaap_DeferredRevenueCurrent 14,722us-gaap_DeferredRevenueCurrent
Total current liabilities 25,974us-gaap_LiabilitiesCurrent 27,016us-gaap_LiabilitiesCurrent
Warrant liability 3,961us-gaap_DerivativeLiabilitiesNoncurrent 23,421us-gaap_DerivativeLiabilitiesNoncurrent
Deferred revenue, non-current 62,194us-gaap_DeferredRevenueNoncurrent 76,916us-gaap_DeferredRevenueNoncurrent
Deferred rent 243us-gaap_DeferredRentCreditNoncurrent 240us-gaap_DeferredRentCreditNoncurrent
Total liabilities 92,372us-gaap_Liabilities 127,593us-gaap_Liabilities
Commitments and contingencies (Note 7)      
Stockholders’ equity (deficit):    
Preferred stock, $0.001 par value, 2,000,000 shares authorized; no shares issued and outstanding      
Common stock, $0.001 par value: Authorized: 150,000,000 shares at December 31, 2014 and 2013; Issued and outstanding: 62,898,233 and 59,232,611 shares at December 31, 2014 and 2013, respectively. 63us-gaap_CommonStockValue 59us-gaap_CommonStockValue
Additional paid-in capital 349,236us-gaap_AdditionalPaidInCapitalCommonStock 328,116us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated other comprehensive (loss) income (13)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 28us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated deficit (373,262)us-gaap_RetainedEarningsAccumulatedDeficit (351,678)us-gaap_RetainedEarningsAccumulatedDeficit
Total stockholders’ equity (deficit) (23,976)us-gaap_StockholdersEquity (23,475)us-gaap_StockholdersEquity
Total liabilities and stockholders’ equity (deficit) $ 68,396us-gaap_LiabilitiesAndStockholdersEquity $ 104,118us-gaap_LiabilitiesAndStockholdersEquity